Sujentec Rises 13.32% Amid Uptrend in COVID-19 (Diagnostics/Treatment/Vaccine Development) Theme

On the 22nd, the COVID-19 (diagnosis/treatment/vaccine development, etc.) theme rose by 3.07% compared to the previous day, showing strength, while SuzenTec, a related stock attracting attention, surged by 13.32% compared to the previous day. SuzenTec is known as a manufacturer and seller of medical devices and diagnostic reagents.

[Graph] Major stock price changes in the COVID-19 (diagnosis/treatment/vaccine development, etc.) theme



According to the analysis by Thinkpool Robo Algorithm RASSI, SuzenTec’s quant financial score is 9.97 points, with higher growth and stability scores than the average of other stocks related to COVID-19 (diagnosis/treatment/vaccine development, etc.), but its quant financial ranking was only 29th out of 47 stocks. On the other hand, United Pharm ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to other stocks.

[Table] Top stocks by financial score within the theme


※ The quant financial score is the result of analysis by the Robo Algorithm based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.